229 related articles for article (PubMed ID: 21767321)
1. Liver X receptor activation enhances blood-brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells.
ElAli A; Hermann DM
Brain Pathol; 2012 Mar; 22(2):175-87. PubMed ID: 21767321
[TBL] [Abstract][Full Text] [Related]
2. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
[TBL] [Abstract][Full Text] [Related]
4. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
[TBL] [Abstract][Full Text] [Related]
5. Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells.
Saint-Pol J; Candela P; Boucau MC; Fenart L; Gosselet F
Brain Res; 2013 Jun; 1517():1-15. PubMed ID: 23603412
[TBL] [Abstract][Full Text] [Related]
6. ABCA1 upregulating apolipoproein M expression mediates via the RXR/LXR pathway in HepG2 cells.
Di D; Wang Z; Liu Y; Luo G; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Biochem Biophys Res Commun; 2012 Apr; 421(1):152-6. PubMed ID: 22516753
[TBL] [Abstract][Full Text] [Related]
7. Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2.
Noghero A; Perino A; Seano G; Saglio E; Lo Sasso G; Veglio F; Primo L; Hirsch E; Bussolino F; Morello F
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2280-8. PubMed ID: 22723445
[TBL] [Abstract][Full Text] [Related]
8. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G
Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
[TBL] [Abstract][Full Text] [Related]
9. Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages.
Shridas P; Bailey WM; Gizard F; Oslund RC; Gelb MH; Bruemmer D; Webb NR
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2014-21. PubMed ID: 20844270
[TBL] [Abstract][Full Text] [Related]
10. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
Verschuren L; de Vries-van der Weij J; Zadelaar S; Kleemann R; Kooistra T
J Lipid Res; 2009 Feb; 50(2):301-11. PubMed ID: 18757914
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment.
Jasmin SB; Pearson V; Lalonde D; Domenger D; Théroux L; Poirier J
Brain Res; 2014 May; 1562():39-51. PubMed ID: 24661912
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.
Narang VS; Fraga C; Kumar N; Shen J; Throm S; Stewart CF; Waters CM
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C440-50. PubMed ID: 18524938
[TBL] [Abstract][Full Text] [Related]
13. ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice.
Donkin JJ; Stukas S; Hirsch-Reinshagen V; Namjoshi D; Wilkinson A; May S; Chan J; Fan J; Collins J; Wellington CL
J Biol Chem; 2010 Oct; 285(44):34144-54. PubMed ID: 20739291
[TBL] [Abstract][Full Text] [Related]
14. Unsaturated fatty acids repress expression of ATP binding cassette transporter A1 and G1 in RAW 264.7 macrophages.
Ku CS; Park Y; Coleman SL; Lee J
J Nutr Biochem; 2012 Oct; 23(10):1271-6. PubMed ID: 22209005
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of Liver X Receptor Has Potent Anti-HIV Effects in a Humanized Mouse Model of HIV Infection.
Ramezani A; Dubrovsky L; Pushkarsky T; Sviridov D; Karandish S; Raj DS; Fitzgerald ML; Bukrinsky M
J Pharmacol Exp Ther; 2015 Sep; 354(3):376-83. PubMed ID: 26126533
[TBL] [Abstract][Full Text] [Related]
16. Liver X receptor activation attenuates plaque formation and improves vasomotor function of the aortic artery in atherosclerotic ApoE(-/-) mice.
Chen J; Zhao L; Sun D; Narsinh K; Li C; Zhang Z; Qi S; Wei G; Li W; Guo W; Cao F
Inflamm Res; 2012 Dec; 61(12):1299-307. PubMed ID: 22833121
[TBL] [Abstract][Full Text] [Related]
17. LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.
Spillmann F; Van Linthout S; Miteva K; Lorenz M; Stangl V; Schultheiss HP; Tschöpe C
Atherosclerosis; 2014 Jan; 232(1):1-9. PubMed ID: 24401210
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptors inhibit macrophage proliferation through downregulation of cyclins D1 and B1 and cyclin-dependent kinases 2 and 4.
Pascual-García M; Carbó JM; León T; Matalonga J; Out R; Van Berkel T; Sarrias MR; Lozano F; Celada A; Valledor AF
J Immunol; 2011 Apr; 186(8):4656-67. PubMed ID: 21398609
[TBL] [Abstract][Full Text] [Related]
19. Neural Progenitor Cell-Derived Extracellular Vesicles Enhance Blood-Brain Barrier Integrity by NF-κB (Nuclear Factor-κB)-Dependent Regulation of ABCB1 (ATP-Binding Cassette Transporter B1) in Stroke Mice.
Zhang L; Graf I; Kuang Y; Zheng X; Haupt M; Majid A; Kilic E; Hermann DM; Psychogios MN; Weber MS; Ochs J; Bähr M; Doeppner TR
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1127-1145. PubMed ID: 33327747
[TBL] [Abstract][Full Text] [Related]
20. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
